Blue Trust’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Blue Trust's ROIV Position: Q3 2026 in Review
Blue Trust increased its Roivant Sciences (ROIV) stake by 76% in Q3 2026, buying an estimated $4.93K and bringing the position to 315 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.
Blue Trust first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.8K in Q3 2024. 430 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Blue Trust held 315 shares of Roivant Sciences worth $11.5K as of Q3 2026.
- Blue Trust bought 136 Roivant Sciences shares in Q3 2026, an estimated $4.93K.
- Roivant Sciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1664 holding.
- Blue Trust first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
- Blue Trust's Roivant Sciences position peaked at $12.8K in Q3 2024.
- 430 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.